4a38e329-9b86-487d-b12c-1155be566e89.gif Kirby Institute News | December 2018 Facebook Twitter Youtube Donate

Happy Holidays
from the Kirby Institute


2018 has been an enormous year for the Kirby Institute, and as the year draws to a close, it is a time to reflect on all that we have gained, and lost, in the past 12 months. 

In the last quarter alone, we have released our Annual Surveillance Reports on HIV, viral hepatitis and STIs, along with the results of EPIC-NSW, the largest population-scale trial of the HIV preventative medication, PrEP. Both these reports are significant, as they have and will continue to inform health policy in Australia, and overseas. We continue to launch impactful new studies, which you can read more about in the research highlights below.

We are also very proud of some academic promotions, which will commence in 2019; Greg Dore was promoted to Scientia Professor, UNSW Sydney's highest academic accolade. He is the Kirby Institute's third Scientia Professor, following the late David Cooper, as well as John Kaldor. Jason Grebely and Andrew Vallely were promoted to Professor for their work in hepatitis C and STIs in Papua New Guinea respectively. Mark Polizzotto and Angela Kelly-Hanku will commence 2019 as Associate Professors. We congratulate our colleagues, who are leaders in their respective fields, on their well-deserved promotions.

The loss of our Director, Professor David Cooper, in March was a significant event for the Kirby, however, we were both moved and inspired by the inundation of support from far and wide during this difficult time. Most of all, we have been invigorated to continue forward with our work in honour of David's vision of equitable access to health for all people, no matter their circumstances. In this vein, there have been some tremendous successes. 

We wish you all a safe and happy holiday period, and look forward to keeping in touch in the new year.

4a38e329-9b86-487d-b12c-1155be566e89.gif 4a38e329-9b86-487d-b12c-1155be566e89.gif
First national survey of trans and gender diverse sexual health to be launched in Australia Read More
Read the 2018 HIV, viral hepatitis and STIs in Australia: Annual Surveillance Report
Read More
90% decline in genital warts in young Australians Read More
Understanding contemporary experiences of living with HIV in Australia
Read More
HIV diagnoses hit seven year low: Check out the latest HIV figures in Australia
Read More
EPIC-NSW: PrEP trial leads to unprecedented reductions in HIV transmission Read More
News and Events
Happy Holidays from the Kirby Institute

Our offices will be closed from Wednesday 19 December 2018 until Wednesday 2 January 2019. 

From all of us, we thank you for your support this year, and wish you a safe and happy festive season. See you in 2019!
Congratulations Scientia Professor Greg Dore

We were delighted to announce that Greg Dore, Head of the Viral Hepatitis Clinical Research Program, was appointed UNSW Scientia Professor this month. 

Read more
Data website: Explore the latest data on HIV, viral hepatitis and STIs

Our interactive data website allows you to explore the latest figures on HIV, viral hepatitis and sexually transmissible infections in Australia.

Read more
University of Medicine 2 in Myanmar honours David Cooper with the opening of new laboratory

Our partners in the Myanmar-Australia Research Collaboration for Health (MARCH) paid respect to the work of the late Professor David Cooper by naming their new laboratory in his honour.

Read more
HIV research given a boost with half a million dollar grant

ViiV Healthcare and the Kirby Institute launched the Cooper HIV/AIDS Research Training (CHART) Program, to support healthcare professionals in the Asia Pacific region, to address national HIV priorities.

Read more
Kirby Institute Annual Report 2017

Learn more about the Kirby Institute's work, and see some of our research achievements from 2017.

Read more

Kirby Institute researchers host workshop to enhance skills in Anal Cancer detection

In November, we hosted the first of a series of workshops training GPs in techniques to improve screening for anal cancer, thanks to generous ongoing funding from The Glendonbrook Foundation. 

Read more
Kirby Institute research receives $4million in NHMRC funding

Research on the sexual health and wellbeing of Australians, HPV vaccination in South African adolescent girls, and improving early treatment initiation for HIV has been supported by almost $4million in the latest round of National Health and Medical Research Council (NHMRC) funding. 

Read more
Kirby in the Media
World first study to explore experiences of people recently diagnosed with HIV (Star Observer, 11 Dec 18)

Indigenous HIV infection rate rises 41 per cent, sparking call for better prevention messaging (ABC News, 6 Dec 18)

HIV in Australia on the rise in heterosexuals (, 30 Nov 18)

Healthcare worker protection: The key to pandemic containment (Healthcare Facilities Today, 30 Nov 18)

What it's like navigating HIV when you're in a serodiscordant relationship (Star Observer, 30 Nov 18)

Australia-First HIV Home Test Could Help Curb Stigma (10 Daily, 30 Nov 18)

HCV reinfection uncommon in injection drug users after treatment (Healio, 11 Nov 18)

Trachoma on track to be eliminated in Australia within two years, health officials say (ABC News, 6 Nov 18)

Kirby Institute announces trans & gender diverse sexual health survey (OUTinPerth, 30 Oct 18)

$500K grant realises HIV researcher David Cooper’s vision to help developing nations (Southern Courier, 28 Oct 18)

Have Your Say In First National Survey of Trans And Gender Diverse Sexual Health (QNews, 28 Oct 18)

Record High Number Of HIV-Positive Gay Men With An Undetectable Viral Load (QNews, 24 Oct 18)

Australia Progressing Toward Hepatitis C Elimination (MD Magazine, 23 Oct 18)

This Blue Pill Has Been Proving To Halt The Spread HIV In Its Tracks (India Times, 19 Oct 18)

Groundbreaking Australian HIV trial should be replicated, researchers say (The Guardian, 18 Oct 18)

A Blue Pill Is Stopping HIV, World-First Study Shows (Bloomberg, 18 Oct 18)

HIV prevention drugs could dramatically cut new infections (Reuters, 18 Oct 18)

Scaled-Up PrEP Cut New HIV Cases in Australia (Newsline, 18 Oct 18)

Drop in Australia HIV sparks call for expanded drug distribution (GMA News, 18 Oct 18)
PrEP can 'significantly' reduce HIV rates across populations, study says (CNN, 17 Oct 18)

PrEP: NHS 'must urgently offer' HIV breakthrough nationwide as study shows infections cut 25% in a year (Independent, 17 Oct 18)

A vaccine for gonorrhoea? (Radio National, 14 Oct 18)

Experts Call For Easing Of Australia's Gay Blood Donation Ban (QNews, 9 Oct 18)

Genital warts reduced, but stable in older Australians (AJP, 5 Oct 18)

Mass drug administration could eliminate neglected tropical diseases (Scitech Europa, 2 Oct 18)

Meta-analysis shows hepatitis C treatment is highly effective for drug users (aidsmap, 28 Sep 18)

HIV diagnoses are rising amongst straight men in Australia (The Brag, 27 Sep 18)

New study disputes claims PrEP is leading to a rise in STI rates (, 26 Sep 18)

Hepatitis C Therapies Work For Drug Users Too (Precision Vaccinations, 24 Sep 18)

Australian HIV rates declining overall, but not for everyone (ABC News, 24 Sep 18)

HIV rates on rise among heterosexuals in Australia (The Guardian, 24 Sep 18)

HIV surge in straight men: Number of Australian heterosexuals diagnosed with the virus soars - and almost half are unaware they have it (Daily Mail, 24 Sep 18)

HIV rates continue to increase in Aboriginal and Torres Strait Islander communities (The World Today, 24 Sep 18)

HIV on the rise in straight Australian men, Kirby Institute report (Sydney Morning Herald, 23 Sep 18)

Overwhelming evidence shows hepatitis C treatment effective for people who inject drugs (Science Daily, 21 Sep 18)

How close is Australia to becoming the first country to end HIV transmission? (RACGP, 20 Sep 18)

Ageing with HIV: 'Stigma will kill you before the disease' (ABC News, 9 Sep 18)

Syphilis in northern communities (The Saturday Paper, 8 Sep 18)